Dishman Pharmaceuticals reports 13% rise in Q3 consolidated net profit

14 Feb 2017 Evaluate

Dishman Pharmaceuticals and Chemicals has reported results for third quarter ended December 31, 2016.  

The company has reported 5.35% fall in its net profit at Rs 16.11 crore for the quarter under review as compared to Rs 17.02 crore for the same quarter in the previous year. Total income of the company decreased by 19.56% at Rs 107.03 crore for the quarter under review as compared Rs 133.05 crore for the corresponding quarter previous year.       

On the consolidated basis, the company has reported a rise of 13.23% in its net profit after taxes, minority interest and share of profit of associates at Rs 50.68 crore for the quarter ended December 31, 2016, as compared to Rs 44.76 crore for the same quarter in the previous year. However, total income of the company decreased by 3.39% at Rs 377.60 crore for the quarter under review as compared Rs 390.85 crore for the corresponding quarter previous year.

Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×